DRDx's Series A Round

DRDx raised a round of funding on January 07, 2013.

DRDx is a company which specialized in drug response. They are developing a biomarker test kit for rheumatoid arthritis treatment guidance with so-called TNF-alpha inhibitors.…

Articles about DRDx's Series A Round: